<--- Back to Details
First PageDocument Content
Arthritis / Rheumatology / Connective tissue diseases / National Institute of Arthritis and Musculoskeletal and Skin Diseases / NIH Intramural Research Program / Autoimmune diseases / Anakinra / Interleukin 1 receptor antagonist / Periodic fever syndrome / Health / Medicine / National Institutes of Health
Date: 2011-10-31 10:43:00
Arthritis
Rheumatology
Connective tissue diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
NIH Intramural Research Program
Autoimmune diseases
Anakinra
Interleukin 1 receptor antagonist
Periodic fever syndrome
Health
Medicine
National Institutes of Health

NIAMS IRPartners Fall/Winter[removed]A newsletter for

Add to Reading List

Source URL: niams.nih.gov

Download Document from Source Website

File Size: 923,82 KB

Share Document on Facebook

Similar Documents

25SA16A ________________________________________________________________________________________________________ Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases Anthony

DocID: 1voae - View Document

National Institute of Allergy and Infectious Diseases Awards MERS/SARS Coronavirus Drug Research Grant to Autoimmune Technologies FOR IMMEDIATE RELEASE New Orleans, June 24, Autoimmune Technologies LLC, a New Orle

DocID: 1uTGp - View Document

The Microbiome, which feeds a myriad of Autoimmune Diseases PRESENTED BY PROFESSOR TREVOR G MARSHALL Autoimmunity Research Foundation, CA, USA Murdoch University, Western Australia Autoimmunity Congress Granada, Spain, M

DocID: 1upLN - View Document

BioMed 258 Final Paper Eve Nakamura Autoimmune Cytopenias Autoimmune diseases are caused by a combination of genetic, epigenetic, and environmental factors and

DocID: 1u7zf - View Document

Medicine / Biology / Clinical medicine / Biotechnology / Immunology / ActoBiotics / Autoimmune diseases / Bacteriology / Biopharmaceutical / Immunogenicity / Mucositis / Human microbiota

Overview ActoBiotics® Platform: A Novel Class of Oral Biotherapeutics

DocID: 1rtnN - View Document